News

May 21, 2026

Blood test powered by AI could transform diagnosis of dementia

New tool can distinguish among major neurodegenerative diseases with goal of providing clarity for treatment decisions.

News Release

February 4, 2026

Scientists discover brain network that may cause Parkinson’s disease

Source: Scientific American

February 4, 2026

Brain network responsible for Parkinson’s disease identified

Patients receiving treatments targeted to the network, rather than to nearby brain regions, experience larger improvements.

News Release

July 14, 2025

WashU Medicine selected for Parkinson’s disease training program

Edmond J. Safra Fellowship to fund training of movement disorder specialist in the Department of Neurology.

Medical Campus & Community, National Leaders

February 7, 2024

How does waste leave the brain?

Discovered route serves as passageway to clear fluid waste from brain.

News Release

October 5, 2021

$35 million to support study of sleep disorder linked to neurodegeneration

International team seeks hidden signs of brain damage in REM behavior disorder.

News Release

July 8, 2021

New Alzheimer’s treatment targets identified

Study points to FDA-approved drugs that have potential to slow or reverse brain damage.

News Release

October 6, 2020

Brain inflammation in Parkinson’s disease focus of $3.2 million grant

Study probes inflammation’s role in spreading brain damage; may have implications for MS, Alzheimer’s, other neurodegenerative diseases.

News Release

June 4, 2020

$3.7 million aimed at studying effect of manganese exposure on cognitive skills

Study of welders could shine light on early stages of Parkinson’s disease.

News Release

February 5, 2020

Gene ID’d as potential therapeutic target for dementia in Parkinson’s

Targeting gene linked to Alzheimer’s may reduce dementia risk in Parkinson’s.

News Release

December 10, 2019

Why doesn’t deep-brain stimulation work for everyone?

Personalized brain maps could improve treatment for Parkinson's disease, other neurological conditions.

News Release

March 26, 2019

Rineys give $15 million to develop, test therapies for neurodegenerative diseases

Gift will fund Alzheimer’s, Parkinson’s research.

News Release